A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

Clinical trial NCT07328009 · RECRUITING

Trial details

NCT number: NCT07328009
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2026-01-19
Primary completion: 2029-01-15
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.